{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:04Z","timestamp":1791357244532,"version":"4.3.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jagp.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T11:40:20Z","timestamp":1565350820000},"page":"23-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["A Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics on Time to Rehospitalization Within 1 Year of Discharge in Elderly Patients With Schizophrenia"],"prefix":"10.1016","volume":"28","author":[{"given":"Ching-Hua","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Chua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Yu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2019.08.005_bib0001","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/YCO.0b013e3282f0f09d","article-title":"The many faces of psychosis in the elderly","volume":"20","author":"Broadway","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1017\/S1092852900026304","article-title":"Treatment adherence and long-term outcomes","volume":"12","author":"Kane","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jagp.2019.08.005_bib0003","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/s-2007-992141","article-title":"Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up","volume":"40","author":"De Haan","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0004","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2165\/00002512-200320150-00003","article-title":"Long-acting injectable antipsychotics in the elderly: guidelines for effective use","volume":"20","author":"Masand","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jagp.2019.08.005_bib0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/JGP.0b013e318198776d","article-title":"Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms","volume":"17","author":"Uchida","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0006","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/JCP.0000000000001090","article-title":"Is antipsychotic treatment associated with risk of pneumonia in people with serious mental illness? The roles of severity of psychiatric symptoms and global functioning","volume":"39","author":"Chan","year":"2019","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jagp.2019.08.005_bib0007","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0924-977X(97)00045-X","article-title":"Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy","volume":"8","author":"Kane","year":"1998","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jagp.2019.08.005_bib0008","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00003495-199447050-00004","article-title":"Depot antipsychotic drugs. Place in therapy","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.jagp.2019.08.005_bib0009","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/ijnp\/pyz035","article-title":"Time to rehospitalization in patients with schizophrenia receiving long-acting injectable antipsychotics or oral antipsychotics","volume":"22","author":"Lin","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jagp.2019.08.005_bib0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/2045125314540297","article-title":"The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal","volume":"4","author":"Brissos","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.jagp.2019.08.005_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.15032su1","article-title":"The use of long-acting injectable antipsychotics in schizophrenia: evaluating the evidence","volume":"77","author":"Correll","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0012","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0013","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.pra.0000388626.98662.a0","article-title":"Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines","volume":"16","author":"Velligan","year":"2010","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.jagp.2019.08.005_bib0014","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/hup.877","article-title":"Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients","volume":"22","author":"Kissling","year":"2007","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.jagp.2019.08.005_bib0015","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1017\/S1041610208007606","article-title":"Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidone","volume":"20","author":"Tadger","year":"2008","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2019.08.005_bib0016","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00023210-200013020-00004","article-title":"Schizophrenia in the Elderly","volume":"13","author":"Sajatovic","year":"2000","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jagp.2019.08.005_bib0017","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00002512-200017050-00004","article-title":"Antipsychotic-induced movement disorders in the elderly: epidemiology and treatment recommendations","volume":"17","author":"Caligiuri","year":"2000","journal-title":"Drugs Aging"},{"issue":"Suppl 8","key":"10.1016\/j.jagp.2019.08.005_bib0018","first-page":"43","article-title":"Side effects of antipsychotics in the elderly","volume":"61","author":"Masand","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0019","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th ed., Text Revision","year":"2000"},{"key":"10.1016\/j.jagp.2019.08.005_bib0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.jagp.2019.08.005_bib0021","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/104012371602800410","article-title":"Depot antipsychotics: where do we stand?","volume":"28","author":"Khan","year":"2016","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0022","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2288-10-20","article-title":"Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer","volume":"10","author":"Bellera","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jagp.2019.08.005_bib0023","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0010-440X(89)90113-2","article-title":"Why must some schizophrenic patients be involuntarily committed? The role of insight","volume":"30","author":"McEvoy","year":"1989","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0024","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/070674371105600608","article-title":"Long-acting injectable antipsychotics: an expert opinion from the Association des m\u00e9decins psychiatres du Qu\u00e9bec","volume":"56","author":"Stip","year":"2011","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/j.1440-1614.2000.00813.x","article-title":"Community treatment orders: relationship to clinical care, medication compliance, behavioural disturbance and readmission","volume":"34","author":"Vaughan","year":"2000","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0026","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00005053-200109000-00003","article-title":"Effects of involuntary outpatient commitment and depot antipsychotics on treatment adherence in persons with severe mental illness","volume":"189","author":"Swartz","year":"2001","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.jagp.2019.08.005_bib0027","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/j.1440-1614.2006.01844.x","article-title":"Effectiveness of community treatment orders for treatment of schizophrenia with oral or depot antipsychotic medication: clinical outcomes","volume":"40","author":"Muirhead","year":"2006","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186768","article-title":"Risk factors for readmission in schizophrenia patients following involuntary admission","volume":"12","author":"Hung","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jagp.2019.08.005_bib0029","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/schbul\/sbu128","article-title":"Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study","volume":"41","author":"Nielsen","year":"2015","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jagp.2019.08.005_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2217\/npy.11.24","article-title":"Comparison of long-acting antipsychotic injection and oral antipsychotics in schizophrenia","volume":"1","author":"Olivares","year":"2011","journal-title":"Neuropsychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0031","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00023210-200216070-00004","article-title":"Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics","volume":"16","author":"Csernansky","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jagp.2019.08.005_bib0032","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1176\/appi.ps.52.8.1100","article-title":"Factors associated with readmission to a psychiatric facility","volume":"52","author":"Bernardo","year":"2001","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jagp.2019.08.005_bib0033","first-page":"25","article-title":"Factors influencing inpatient duration among insanity acquittees in a Malaysian Mental Institution","volume":"11","author":"Fong","year":"2010","journal-title":"Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0034","first-page":"625","article-title":"Social support and length of hospital stay among schizophrenic patients","volume":"19","author":"Ossman","year":"2012","journal-title":"World Appl Sci J"},{"key":"10.1016\/j.jagp.2019.08.005_bib0035","series-title":"Principles and Practice of Geriatric Psychiatry","author":"Agronin","year":"2011"},{"key":"10.1016\/j.jagp.2019.08.005_bib0036","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1192\/bjp.195.52.s13","article-title":"Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review","volume":"52","author":"Taylor","year":"2009","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/j.jagp.2019.08.005_bib0037","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4088\/JCP.09m05155yel","article-title":"A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia","volume":"71","author":"Chan","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0038","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/0269881108096070","article-title":"A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism","volume":"24","author":"Chan","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jagp.2019.08.005_bib0039","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/YCO.0000000000000160","article-title":"Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevance","volume":"28","author":"Haddad","year":"2015","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.005_bib0040","first-page":"754","article-title":"Antipsychotic adherence and rehospitalization in schizophrenia patients receiving oral versus long-acting injectable antipsychotics following hospital discharge","volume":"21","author":"Marcus","year":"2015","journal-title":"J Manag Care Spec Pharm"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748119304683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748119304683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:28:48Z","timestamp":1761020928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748119304683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1064748119304683"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2019.08.005","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comparison of Long-Acting Injectable Antipsychotics With Oral Antipsychotics on Time to Rehospitalization Within 1 Year of Discharge in Elderly Patients With Schizophrenia","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}